ERBB2 and breast cancer: Furthermore, CircGFRA1 is predominantly present in the cytoplasm, suggesting that it can intersect with most miRNAs located in the cytoplasm, promoting the malignant progression of HER-2-positive breast cancer by acting as a sponge for miR-1228 and enhancing AIFM2 expression.